Discovery and Validation of a New Class of Small Molecule Toll-Like Receptor 4 (TLR4) Inhibitors
Open Access
- 12 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6), e65779
- https://doi.org/10.1371/journal.pone.0065779
Abstract
Many inflammatory diseases may be linked to pathologically elevated signaling via the receptor for lipopolysaccharide (LPS), toll-like receptor 4 (TLR4). There has thus been great interest in the discovery of TLR4 inhibitors as potential anti-inflammatory agents. Recently, the structure of TLR4 bound to the inhibitor E5564 was solved, raising the possibility that novel TLR4 inhibitors that target the E5564-binding domain could be designed. We utilized a similarity search algorithm in conjunction with a limited screening approach of small molecule libraries to identify compounds that bind to the E5564 site and inhibit TLR4. Our lead compound, C34, is a 2-acetamidopyranoside (MW 389) with the formula C 17 H 27 NO 9, which inhibited TLR4 in enterocytes and macrophages in vitro, and reduced systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis. Molecular docking of C34 to the hydrophobic internal pocket of the TLR4 co-receptor MD-2 demonstrated a tight fit, embedding the pyran ring deep inside the pocket. Strikingly, C34 inhibited LPS signaling ex-vivo in human ileum that was resected from infants with necrotizing enterocolitis. These findings identify C34 and the β-anomeric cyclohexyl analog C35 as novel leads for small molecule TLR4 inhibitors that have potential therapeutic benefit for TLR4-mediated inflammatory diseases.This publication has 35 references indexed in Scilit:
- Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epitheliumProceedings of the National Academy of Sciences of the United States of America, 2012
- Disease Tolerance as a Defense StrategyScience, 2012
- Toll-like receptors expression and interferon-γ production by NK cells in human sepsisCritical Care, 2012
- Toll-Like Receptor 4 Is Involved in Inflammatory and Joint Destructive Pathways in Collagen-Induced Arthritis in DBA1J MicePLOS ONE, 2011
- New Insights Into the Pathogenesis and Treatment of Necrotizing Enterocolitis: Toll-Like Receptors and BeyondPediatric Research, 2011
- Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesExpert Opinion on Drug Metabolism & Toxicology, 2011
- A Novel Aminosaccharide Compound Blocks Immune Responses by Toll-like Receptors and Nucleotide-binding Domain, Leucine-rich Repeat ProteinsOnline Journal of Public Health Informatics, 2011
- Necrotizing EnterocolitisThe New England Journal of Medicine, 2011
- Nucleotide-Binding Oligomerization Domain-2 Inhibits Toll-Like Receptor-4 Signaling in the Intestinal EpitheliumGastroenterology, 2010
- Toll-Like Receptor-4 Inhibits Enterocyte Proliferation via Impaired β-Catenin Signaling in Necrotizing EnterocolitisGastroenterology, 2010